Valuation China Resources Pharmaceutical Group Limited

Stocks

Delayed Hong Kong S.E. Other stock markets 09:10:00 05/08/2026 +04			5-day change	1st Jan Change
4.815 ^HKD	-0.93%		-1.43%	+8.54%

07-29	China Resources Pharmaceutical Holdings Company Limited Completes Issue of Second Tranche of Medium Term Notes 2026 in the Prc	CI
07-22	China Resources Pharma Unit Sells 1 Billion Yuan Bonds	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	30,533	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	9.21%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	84,600	79,174	63,705
Change	-	19.71%	-2.67%	26.95%	0.08%	-6.83%	-6.41%	-19.54%
P/E	5.92x	9.58x	7.76x	10x	6.12x	6.16x	5.77x	5.35x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.48x	0.44x	0.38x
PEG	-	1x	44.15x	-0.7x	0.2x	0.72x	0.84x	0.68x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.09x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.26x	0.23x	0.18x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	4.08x	3.69x	3.04x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	5.08x	4.45x	3.35x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	49.3x	12.9x	7.45x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	2.03%	7.74%	13.4%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.207	0.2257	0.2855
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.26%	4.64%	5.87%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7888	0.8429	0.9092
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.2%	26.8%	31.4%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	326,592	343,358	363,235
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	20,745	21,433	20,955
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,667	17,783	19,040
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,854	5,252	5,706
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	54,067	48,641	33,172
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.860	4.860	4.860
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	29/03/22	30/03/23	26/03/24	26/03/25	24/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	6.17x	0.26x	4.08x	4.25%	3.89B
ELI LILLY AND COMPANY	34.19x	11.9x	25x	0.6%	995B
JOHNSON & JOHNSON	27.59x	6.24x	17.41x	2.11%	614B
ABBVIE INC.	33.42x	7.23x	14.91x	2.82%	431B
ROCHE HOLDING AG	19.84x	4.71x	11.66x	2.81%	353B
NOVARTIS AG	21.78x	5.64x	14.07x	2.85%	293B
ASTRAZENECA PLC	19.76x	4.1x	11.62x	2.15%	245B
NOVO NORDISK A/S	13.29x	4.98x	10.27x	3.76%	210B
AMGEN INC.	24.88x	6.52x	11.5x	2.66%	210B
GILEAD SCIENCES, INC.	-47.26x	5.67x	31.29x	2.51%	168B
Average	15.37x	5.73x	15.18x	2.65%	352.21B
Weighted average by Cap.	23.76x	7.52x	17.86x	2.06%